121 related articles for article (PubMed ID: 38568054)
1. Association between genetically proxied PCSK9 inhibition and systemic lupus erythematosus risk: A mendelian randomization study.
Ji X; Guo HY; Han M; Peng H; Yuan H
Int J Rheum Dis; 2024 Apr; 27(4):e15106. PubMed ID: 38568054
[TBL] [Abstract][Full Text] [Related]
2. Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.
Sun L; Ding H; Jia Y; Shi M; Guo D; Yang P; Wang Y; Liu F; Zhang Y; Zhu Z
Breast Cancer Res; 2022 Feb; 24(1):12. PubMed ID: 35151363
[TBL] [Abstract][Full Text] [Related]
3. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
[TBL] [Abstract][Full Text] [Related]
4. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
Yarmolinsky J; Bull CJ; Vincent EE; Robinson J; Walther A; Smith GD; Lewis SJ; Relton CL; Martin RM
JAMA; 2020 Feb; 323(7):646-655. PubMed ID: 32068819
[TBL] [Abstract][Full Text] [Related]
5. Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug-Target Mendelian Randomization Study.
Bell AS; Rosoff DB; Mavromatis LA; Jung J; Wagner J; Lohoff FW
J Am Heart Assoc; 2022 Nov; 11(21):e026122. PubMed ID: 36285785
[TBL] [Abstract][Full Text] [Related]
6. Associations between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study.
He JY; Zhang X; Wang K; Lv WQ
J Nutr; 2022 May; 152(5):1283-1290. PubMed ID: 35349717
[TBL] [Abstract][Full Text] [Related]
7. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.
Gormley M; Yarmolinsky J; Dudding T; Burrows K; Martin RM; Thomas S; Tyrrell J; Brennan P; Pring M; Boccia S; Olshan AF; Diergaarde B; Hung RJ; Liu G; Legge D; Tajara EH; Severino P; Lacko M; Ness AR; Davey Smith G; Vincent EE; Richmond RC
PLoS Genet; 2021 Apr; 17(4):e1009525. PubMed ID: 33886544
[TBL] [Abstract][Full Text] [Related]
8. Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization.
Wu T; Ye L; Wang S; Huang J; Zhang J
Front Pharmacol; 2023; 14():1258018. PubMed ID: 37964871
[No Abstract] [Full Text] [Related]
9. Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study.
Soremekun O; Karhunen V; He Y; Rajasundaram S; Liu B; Gkatzionis A; Soremekun C; Udosen B; Musa H; Silva S; Kintu C; Mayanja R; Nakabuye M; Machipisa T; Mason A; Vujkovic M; Zuber V; Soliman M; Mugisha J; Nash O; Kaleebu P; Nyirenda M; Chikowore T; Nitsch D; Burgess S; Gill D; Fatumo S
EBioMedicine; 2022 Apr; 78():103953. PubMed ID: 35325778
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus is causally associated with hypothyroidism, but not hyperthyroidism: A Mendelian randomization study.
Qin Q; Zhao L; Ren A; Li W; Ma R; Peng Q; Luo S
Front Immunol; 2023; 14():1125415. PubMed ID: 36860870
[TBL] [Abstract][Full Text] [Related]
11. No evidence of genetic causal association between sex hormone-related traits and systemic lupus erythematosus: A two-sample Mendelian randomization study.
Yuan G; Yang M; Xie J; Xu K; Zhang F
Clin Rheumatol; 2023 Dec; 42(12):3237-3249. PubMed ID: 37495778
[TBL] [Abstract][Full Text] [Related]
12. Association of Lipid-Lowering Drugs With Risk of Psoriasis: A Mendelian Randomization Study.
Zhao SS; Yiu ZZN; Barton A; Bowes J
JAMA Dermatol; 2023 Mar; 159(3):275-280. PubMed ID: 36696131
[TBL] [Abstract][Full Text] [Related]
13. Causal Effects of Gut Microbiome on Systemic Lupus Erythematosus: A Two-Sample Mendelian Randomization Study.
Xiang K; Wang P; Xu Z; Hu YQ; He YS; Chen Y; Feng YT; Yin KJ; Huang JX; Wang J; Wu ZD; Yang XK; Wang DG; Ye DQ; Pan HF
Front Immunol; 2021; 12():667097. PubMed ID: 34557183
[TBL] [Abstract][Full Text] [Related]
14. Alcohol intake and risk of systemic lupus erythematosus: a Mendelian randomization study.
Bae SC; Lee YH
Lupus; 2019 Feb; 28(2):174-180. PubMed ID: 30539684
[TBL] [Abstract][Full Text] [Related]
15. Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study.
Xie W; Li J; Du H; Xia J
Arthritis Res Ther; 2023 Aug; 25(1):148. PubMed ID: 37580807
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus and Atopic dermatitis: A two sample Mendelian randomization study.
Xia Z; Liu J; Zu Y
Clin Rheumatol; 2024 Apr; 43(4):1311-1317. PubMed ID: 38349447
[TBL] [Abstract][Full Text] [Related]
17. Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study.
Dan YL; Wang P; Cheng Z; Wu Q; Wang XR; Wang DG; Pan HF
Rheumatology (Oxford); 2021 Feb; 60(2):940-946. PubMed ID: 32944772
[TBL] [Abstract][Full Text] [Related]
18. Causal Relationship Between Sleep Traits and Risk of Systemic Lupus Erythematosus: A Two-Sample Mendelian Randomization Study.
Sang N; Gao RC; Zhang MY; Wu ZZ; Wu ZG; Wu GC
Front Immunol; 2022; 13():918749. PubMed ID: 35784289
[TBL] [Abstract][Full Text] [Related]
19. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
20. Genetically Predicted Serum Iron Status Is Associated with Altered Risk of Systemic Lupus Erythematosus among European Populations.
Ye D; Zhu Z; Huang H; Sun X; Liu B; Xu X; He Z; Li S; Wen C; Mao Y
J Nutr; 2021 Jun; 151(6):1473-1478. PubMed ID: 33693920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
